4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000147
Director bought 52,189 shares at an average $18.49 ($965,021)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A Director | 2024-12-19 | Purchase | +11,303 | $17.39 | $196,512 | 8,467,009 | D |
| SPRINGER TIMOTHY A Director | 2024-12-19 | Purchase | +10,529 | $18.35 | $193,203 | 8,477,538 | D |
| SPRINGER TIMOTHY A Director | 2024-12-19 | Purchase | +3,376 | $18.93 | $63,901 | 8,480,914 | D |
| SPRINGER TIMOTHY A Director | 2024-12-20 | Purchase | +21,800 | $18.94 | $412,968 | 8,502,714 | D |
| SPRINGER TIMOTHY A Director | 2024-12-23 | Purchase | +5,181 | $19.00 | $98,437 | 8,507,895 | D |
| Open-market purchases · 52,189 sh · avg $18.49 · $965,021 | |||||||
Loading xslF345X05/wk-form4_1734992437.xml…